IN2012DN03015A - - Google Patents

Download PDF

Info

Publication number
IN2012DN03015A
IN2012DN03015A IN3015DEN2012A IN2012DN03015A IN 2012DN03015 A IN2012DN03015 A IN 2012DN03015A IN 3015DEN2012 A IN3015DEN2012 A IN 3015DEN2012A IN 2012DN03015 A IN2012DN03015 A IN 2012DN03015A
Authority
IN
India
Prior art keywords
protein
reduced ability
animals
digest fat
indicative
Prior art date
Application number
Other languages
English (en)
Inventor
Carolyn Jean Cupp
Avinash Patil
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IN2012DN03015A publication Critical patent/IN2012DN03015A/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN3015DEN2012 2009-10-15 2010-10-08 IN2012DN03015A (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27904409P 2009-10-15 2009-10-15
PCT/US2010/002724 WO2011046595A1 (en) 2009-10-15 2010-10-08 Methods for identifying animals with a reduced ability to digest lipid and protein

Publications (1)

Publication Number Publication Date
IN2012DN03015A true IN2012DN03015A (pl) 2015-06-26

Family

ID=43876411

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3015DEN2012 IN2012DN03015A (pl) 2009-10-15 2010-10-08

Country Status (11)

Country Link
US (1) US20120237958A1 (pl)
EP (1) EP2488864A4 (pl)
JP (1) JP2013508678A (pl)
CN (1) CN102576013A (pl)
AU (1) AU2010307305A1 (pl)
BR (1) BR112012008589A2 (pl)
CA (1) CA2777499A1 (pl)
IN (1) IN2012DN03015A (pl)
MX (1) MX2012003931A (pl)
RU (1) RU2012119742A (pl)
WO (1) WO2011046595A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11414380B2 (en) 2015-09-17 2022-08-16 Eastman Chemical Company Amphoteric compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028415A1 (en) * 1999-10-15 2001-04-26 Dodds W Jean Animal health diagnosis
ATE492166T1 (de) * 2002-04-05 2011-01-15 Nestle Sa Zusammensetzungen und verfahren zur verbesserung von lipidassimilation in haustieren

Also Published As

Publication number Publication date
AU2010307305A1 (en) 2012-05-03
BR112012008589A2 (pt) 2016-04-05
JP2013508678A (ja) 2013-03-07
RU2012119742A (ru) 2013-11-20
EP2488864A4 (en) 2013-03-20
WO2011046595A1 (en) 2011-04-21
MX2012003931A (es) 2012-05-08
EP2488864A1 (en) 2012-08-22
US20120237958A1 (en) 2012-09-20
CN102576013A (zh) 2012-07-11
CA2777499A1 (en) 2011-04-21

Similar Documents

Publication Publication Date Title
BR112014031365A2 (pt) métodos de detectar doenças ou condições
WO2012009644A3 (en) Methods to identify synthetic and natural rna elements that enhance protein translation
GB2498163A (en) High-throughput immune sequencing
EP2478360A4 (en) MICRO-RNA, AUTOANTIBODIES AND PROTEIN MARKERS FOR THE DIAGNOSIS OF NEURONAL INJURY
TR201902439T4 (tr) Fukoz analogları kullanarak in vivo protein fukosilasyonunun inhibisyon yöntemleri .
PH12015502216A1 (en) Compositions and methods for improving the health of aquatic animals
WO2012094580A3 (en) Compounds that modulate oxidative stress
EP2315849A4 (en) CIRCULATING MUTANT DNA FOR EVALUATING TUMOR DYNAMICS
IN2012DN02521A (pl)
IN2015DN02479A (pl)
EP4407616C0 (en) Encoding Mode Determination Device
MX336323B (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
UA101814C2 (ru) Фактор, задействованный в латентной инфекции герпесвирусом, и его применение
EA201291206A1 (ru) Мутация в mek1, придающая устойчивость к ингибиторам raf и mek
IN2015DN01501A (pl)
GB201102108D0 (en) Diagnostic method
EP3795694A3 (en) Methods relating to dna-sensing pathway related conditions
HK1206249A1 (en) Human autotaxin antibodies and methods of use
WO2011140334A3 (en) Compounds, methods of making or identifying compounds, and uses thereof
BR112014023496A2 (pt) mutantes c-raf que conferem resistência a inibidores de raf
AU2013231230A8 (en) Method for selecting or identifying a subject for V1B antagonist therapy
PH12015500223B1 (en) Method for manufacturing low-protein rice and food using low-protein rice
IN2012DN03015A (pl)
WO2011141153A8 (en) Methods for the diagnosis and prognosis of a tumor using bcat1 protein
GB2505833A (en) Assessment method